Nairobi, 8th October 2024 – The Pharmacy and Poisons Board (PPB) Clinical Trials Division on October 8th, hosted a meeting with representatives from Genetic Immunity, Hungary. Dr. Anthony Toroitich, representing PPB CEO Dr. F. M. Siyoi, highlighted Kenya’s regulatory framework for clinical trials and emphasized PPB’s dedication to advancing healthcare through safe and ethical research. Key developments, such as the automation of clinical trial systems and global collaborations with AVAREF and WHO, were also discussed. The meeting explored potential partnerships in clinical research to enhance healthcare outcomes.